Concepedia

Publication | Closed Access

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS

DOI

330

Citations

22

References

2007

Year

David H. Miller, Derek Soon, Kryshani Fernando, David MacManus, Gareth J. Barker, Tarek Yousry, Elizabeth Fisher, Paul O’Connor, J. Theodore Phillips, Chris H. Polman,
Neurology

Abstract

Natalizumab has a sustained effect in preventing the formation of new lesions in patients with relapsing multiple sclerosis.

References

YearCitations

Page 1